The clinical effectiveness of individualized physiotherapy and occupational therapy in Parkinson disease (PD) has previously been unclear. The open-label, parallel group, randomized PD REHAB clinical ...

Parkinson’s disease currently affects nearly one million Americans with no specific known cause and no cure. Treatments have come a long way over the past few decades focusing on managing symptoms and ...

MSK physician-scientists Dr. Viviane Tabar and Dr. Lorenz Studer have developed a treatment for Parkinson’s disease that involves creating nerve cells from embryonic stem cells and transplanting them ...

A MeiraGTx Holdings gene therapy for Parkinson’s disease has preliminary data from a small clinical trial showing the one-time treatment showed both safety and efficacy, results that lay the ...

MeiraGTx is looking to march its Parkinson’s disease treatment forward into phase 3 after the gene therapy improved motor ability and quality of life in a small midphase trial. A total of 14 patients ...

A stem cell–based therapy initially developed at Memorial Sloan Kettering Cancer Center (MSK) may lead to a new treatment for advanced Parkinson's disease, according to results from a phase 1 clinical ...

Parkinson’s disease (PD) is one of the fastest-growing neurological disorders in the world, with around 60,000 Americans receiving a Parkinson’s diagnosis each year and nearly 1 million Americans ...

MeiraGTx has one gene therapy in a potentially pivotal clinical trial for cancer patients and another gene therapy ready to start Phase 3 in Parkinson’s disease. Completing the studies will be ...

Northwestern Medicine scientists have discovered that targeting neuronal signaling controlling aberrant learning in the ...